Clinical Trial Update: ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (PUMICE) evaluating ProUrokinase for mild ischemic cerebrovascular events has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ProUrokinase (pro-urokinase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Mild | Phase 3 | Status: COMPLETED